Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details) - Schedule of company???s outstanding warrants and options

v3.22.1
Stockholders’ Equity (Details) - Schedule of company’s outstanding warrants and options
 3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
$1.79 - $20.90 [Member] | Warrants Outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price Range, lower limit $ 1.79
Exercise Price Range, upper limit $ 20.9
Number Outstanding (in Shares) | shares 1,043,525
Weighted Average Remaining Contractual Life (in years) 2 years 8 months 26 days
Weighted Average Exercise Price $ 2.57
$1.79 - $20.90 [Member] | Warrants Exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Exercisable (in Shares) | shares 1,043,525
Weighted Average Exercise Price $ 2.57
Intrinsic Value (in Dollars) | $
$2.64 - $28.50 [Member] | Options Outstanding [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Exercise Price Range, lower limit $ 2.64
Exercise Price Range, upper limit $ 28.5
Number Outstanding (in Shares) | shares 118,388
Weighted Average Remaining Contractual Life (in years) 2 years 5 months 8 days
Weighted Average Exercise Price $ 3.25
$2.64 - $28.50 [Member] | Options Exercisable [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Number Exercisable (in Shares) | shares 118,388
Weighted Average Exercise Price $ 3.25
Intrinsic Value (in Dollars) | $